The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication tirzepatide is over. Tirzepatide includes blockbuster injected GLP-1 medications Mounjaro (for diabetes) and Zepbound (for weight loss). The FDA first announced two months ago that any shortage of the medications observed during… read on > read on >
A little about: Weekly Sauce
All Sauce from Weekly Sauce:
Cold Weather Deaths Keep Rising for Americans
It’s a perhaps unexpected consequence of climate change that periods of deep cold now occur more frequently during American winters, despite an overall trend to warmer temperatures year round. That uptick in cold snaps, along with other possible factors, has been linked to a doubling of U.S. deaths from freezing temperatures since 1999, according to… read on > read on >
DOJ Alleges CVS Facilitated Unlawful Sales, Violating Federal Opioid Regulations
The U.S. Department of Justice (DOJ) has filed a civil complaint against CVS Pharmacy Inc., accusing the nation’s largest pharmacy chain of unlawfully filling prescriptions for highly addictive opioids and violating federal health care laws. According to a news release published Dec. 18, 2024, the complaint also accuses CVS of seeking reimbursement for these prescriptions… read on > read on >
Sleep Apnea May Change Parts of Brain, Speed Aging
Sleep apnea is known to wreak havoc with the body, contributing to heart problems, diabetes and liver disease. The sleep disorder also appears to have direct effects on brain health, a new study shows. People with sleep apnea appear to experience accelerated aging of the brain’s white matter, which serves to connect the various regions… read on > read on >
New Youth Mental Health Program Shows Promise
Teenagers who land in an ER with a mental health crisis can be effectively helped by a community-based program. New research shows that troubled teens placed in such a program were significantly less likely to return to the ER or require inpatient psychiatric care due to a follow-up crisis. The program did not reduce risk… read on > read on >
A New Way to Diagnose Painful ‘Wear-and-Tear’ Arthritis?
Knee arthritis could become easier to detect and diagnose thanks to a new test involving the lubricating fluid inside the joint. A new study shows that arthritis of the knee often is diagnosed in its late stages, after cartilage has degraded and bones are rubbing against each other in the joint. At that point, it’s… read on > read on >
Early Research Points to Possible New Parkinson’s Drug
Parkinson’s is a relentless disease for which few treatments, and no real cure, exists. Now, researchers say they are on the trail of a potential new therapy for the disabling neurological illness. It’s early research, still in the animal-testing stage, as explained by investigators at the University of Arizona in Tucson. However, their findings, published… read on > read on >
Milk Cereal Drinks for Infants May Trigger Weight Gain
Adding cereal to a baby’s bottle is a habit that’s been around for a long time to help introduce solid foods while also supplementing a mom’s breast milk. But this practice can cause babies to pack on some pounds early in life, however, a new study says. Infants were about 50% more likely to experience… read on > read on >
Patient Hospitalized in Louisiana With First U.S. Case of Severe Bird Flu
In a case first reported in Louisiana last Friday, a patient has now developed the first known case of bird flu so severe as to require hospitalization, according to the U.S. Centers for Disease Control and Prevention (CDC). Sixty other cases of H5N1 avian flu have been reported in people across the United States since… read on > read on >
FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning
The U.S. Food and Drug Administration (FDA) has issued its most serious warning — a black-box warning — for Veozah, a medication used to relieve hot flashes in menopausal women, due to rare but potentially severe liver risks. In new communication issued Dec. 17, the FDA advised that women taking Veozah should undergo regular blood… read on > read on >